Christopher P Millward, Sumirat M Keshwara, Terri S Armstrong, Heather Barrington, Sabrina Bell, Andrew R Brodbelt, Helen Bulbeck, Linda Dirven, Paul L Grundy, Abdurrahman I Islim, Mohsen Javadpour, Shelli D Koszdin, Anthony G Marson, Michael W McDermott, Torstein R Meling, Kathy Oliver, Puneet Plaha, Matthias Preusser, Thomas Santarius, Nisaharan Srikandarajah, Martin J B Taphoorn, Carole Turner, Colin Watts, Michael Weller, Paula R Williamson, Gelareh Zadeh, Amir H Zamanipoor Najafabadi, Michael D Jenkinson
BACKGROUND: Meningioma clinical trials have assessed interventions including surgery, radiotherapy, and pharmacotherapy. However, agreement does not exist on what, how, and when outcomes of interest should be measured. To do so would allow comparative analysis of similar trials. This systematic review aimed to summarize the outcomes measured and reported in meningioma clinical trials. METHODS: Systematic literature and trial registry searches were performed to identify published and ongoing intracranial meningioma clinical trials (PubMed, Embase, Medline, CINAHL via EBSCO, and Web of Science, completed January 22, 2022)...
2024: Neuro-oncology advances